News

Filter

Current filters:

HematologyTretten

1 to 9 of 95864 results

Clinigen adds to oncology portfolio with AztraZeneca’s Ethyol

Clinigen adds to oncology portfolio with AztraZeneca’s Ethyol

20-08-2014

UK-based Clinigen Group has acquired the global rights to the oncology support therapy Ethyol (amifostine)…

ClinigenClinigen GroupEthyolLicensingOncologyPharmaceuticalTreatment for head and neck cancerUK

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

20-08-2014

UK drugs watch dog the National Institute for Health and Care Excellence (NICE) has issued final draft…

BiotechnologyCelgene Corp.Myelodysplastic syndromesOncologyPricingRegulationRevlimidUK

Depomed prevails in Gralise ANDA litigation with Actavis

Depomed prevails in Gralise ANDA litigation with Actavis

20-08-2014

US drug maker Depomed saw its shares climb more than 12% to $14.76 on Tuesday, on the news that the firm…

ActavisDepomedGraliseLegalNeurologicalPatentsPharmaceuticalUSA

1 to 9 of 95864 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top